Latest Cancer News
The new findings were published in the September issue of the journal Cancer Discovery.
"In our study we saw that in all outcomes, including immunogenicity [the ability of the vaccine to provoke an immune response], infectivity rate throughout the six months and safety, patients with solid tumors depicted a similar trend as the general population," lead researcher Irit Ben-Aharon said in a journal news release. She is director of the oncology division at Rambam Health Care Campus in Israel.
Ben-Aharon said these data can inform recommendations for booster shots.
The National Comprehensive Cancer Network -- a nonprofit alliance of 31 U.S. cancer centers -- recommends that patients with blood cancers and those who had hematopoietic cell transplants or cellular therapy get booster shots first, followed by patients with solid tumors.
SOURCE: American Association for Cancer Research, press release, Sept. 2, 2021
Copyright © 2021 HealthDay. All rights reserved.